AI-generated summary
The authors compared a low-fluence picosecond alexandrite laser approach with a conventional high-fluence approach for nevus of Ota, using a split-lesion design in 64 participants. They report that low-fluence treatment achieved clearance comparable to high-fluence treatment in the overall group, with higher satisfaction and fewer adverse events in those under 5 years. Older participants had higher clearance with high-fluence treatment, and the authors note limits including lack of objective measures and sample size.
- Participants
- 64
- Who or what was studied
- Participants with nevus of Ota, 38 aged under 5 years and 26 aged over 5 years
- Limits stated in the abstract
- The abstract notes a lack of objective assessments and outcome measures, and a limited sample size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 755 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence, Sample size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.